The reports on healthcare provide information on a broad range of healthcare products like over-the-counter drugs, pharmaceuticals, pet healthcare, nanomedicines, etc. Company profiles of the major players in the market like Alticor Inc, Bayer AG, Beiersdorf AG, Glaxosmithkline Plc, Johnson and Johnson Inc, Novartis AG, Pfizer Inc, Wyeth etc. Our collection of market research reports on healthcare provide insights into product and market trends, analyses, opportunities, projections, sales, and marketing strategies. Specifics on market share, segmentation, size, and growth in the domestic and global markets are also featured.
| Title |
Published |
Price |
| Purdue Pharma L.P.: Pharmaceuticals and Healthcare Company Profile & SWOT Report |
May, 2012 |
$ 125.00 |
| Blue Cross Blue Shield of Michigan: Pharmaceuticals and Healthcare Company Profile & SWOT Report |
May, 2012 |
$ 125.00 |
| Nissan Chemical Industries, Ltd.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report |
May, 2012 |
$ 125.00 |
| EGIS Pharmaceuticals Plc: Pharmaceuticals and Healthcare Company Profile & SWOT Report |
May, 2012 |
$ 125.00 |
| Mitsubishi Tanabe Pharma Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report |
May, 2012 |
$ 125.00 |
| Eisai Co., Ltd.: Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report |
May, 2012 |
$ 125.00 |
| Daiichi Sankyo Company, Ltd: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report |
May, 2012 |
$ 125.00 |
| Asahi Kasei Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report |
May, 2012 |
$ 125.00 |
| Japan Tobacco Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report |
May, 2012 |
$ 125.00 |
| Perrigo Company: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report |
May, 2012 |
$ 125.00 |
| Align Technology, Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report |
May, 2012 |
$ 125.00 |
| Competitor Analysis: Staphylococcus aureus Vaccines and Therapeutics |
May, 2012 |
$ 383.36 |
| Insulin - Mongolia |
May, 2012 |
$ 626.16 |
| Insulin - Nepal |
May, 2012 |
$ 490.00 |
| Insulin - Philippines |
May, 2012 |
$ 626.16 |
| Insulin - Senegal |
May, 2012 |
$ 626.16 |
| Insulin - South Africa |
May, 2012 |
$ 626.16 |
| Insulin - Sudan |
May, 2012 |
$ 626.16 |
| Insulin - Vietnam |
May, 2012 |
$ 626.16 |
| Insulin - Global |
May, 2012 |
$ 25,544.82 |
| Insulin - Europe |
May, 2012 |
$ 14,427.27 |
| Insulin - Asia |
May, 2012 |
$ 10,465.84 |
| Insulin - Americas |
May, 2012 |
$ 4,970.95 |
| Insulin - Africa |
May, 2012 |
$ 4,970.95 |
| Insulin - Eastern Europe |
May, 2012 |
$ 9,443.53 |
| Insulin - Western Europe |
May, 2012 |
$ 6,887.77 |
| Insulin - Top 10 Global Markets |
May, 2012 |
$ 4,970.95 |
| Insulin - Top 5 European Markets |
May, 2012 |
$ 2,415.19 |
| Insulin - Top 5 Asian Markets |
May, 2012 |
$ 2,415.19 |
| Insulin - Top 5 American Markets |
May, 2012 |
$ 2,415.19 |
|
0 items in cart
